Kalypto secures investment for wound-healing system

12/8/2009 | MedCityNews.com

Kalypto Medical secured an investment worth $8.375 million for a wound-therapy device, the company disclosed in a regulatory filing. The portable system, which was cleared by the FDA in October 2008, uses vacuum pressure to treat chronic wounds caused by diabetes, leg ulcers and other circulatory problems.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI